Kepler Capital Markets Upgrades Coloplast A/S (OTCMKTS:CLPBY) to “Strong-Buy”

Coloplast A/S (OTCMKTS:CLPBY) was upgraded by analysts at Kepler Capital Markets to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Several other analysts also recently weighed in on the company. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group downgraded Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Coloplast A/S presently has a consensus rating of “Hold”.

Coloplast A/S Stock Performance

OTCMKTS:CLPBY opened at $6.62 on Wednesday. The stock has a fifty day moving average price of $6.61 and a 200-day moving average price of $7.83. The company has a market cap of $14.91 billion, a price-to-earnings ratio of 47.26, a PEG ratio of 2.04 and a beta of 0.15. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. Coloplast A/S has a fifty-two week low of $6.10 and a fifty-two week high of $10.03.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. As a group, equities analysts anticipate that Coloplast A/S will post 0.4 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.